HeartSciences Files Definitive Proxy Statement for Proposed Business Combination with Fortitude Mining
Stocks in this Quantisnow insightHealth Care
Historical context for HSCS
Across the 26 sessions after earlier HSCS headlines, the stock closed higher 10 times and lower 14 times, with a median move of 2.6% in either direction. This shows timing only: many things move a stock in a session, and these figures do not show that any headline caused a move.
| Session | Earlier headline | HSCS | SPY |
|---|---|---|---|
| Oct 6, 2026 | HeartSciences Receives FDA 510(k) Clearance for its MyoVista® wavECGTM Deviceand 1 other headline that session | -13.5% | +0.5% |
| Sep 30, 2026 | Fortitude Appoints Kimberly Pittman as Chief Legal Officer | +3.2% | -0.2% |
| Sep 24, 2026 | Fortitude Announces Amendment to Existing DCG Credit Facility, Increasing Commitment by $24 Million and Providing for Future Funding in ZEC | +2.4% | -0.1% |
| Sep 17, 2026 | Fortitude Appoints Jaime Leverton as Chief Executive Officer | +27.7% | +1.1% |
| Sep 15, 2026 | HeartSciences Reports Fiscal First Quarter 2027 Financial Results and Provides Business Update | -2.8% | -0.5% |
| Aug 20, 2026 | Fortitude Provides Second Quarter 2026 Financial and Operating Highlights | -2.2% | -0.8% |
Quantisnow market dataNASDAQ
HSCS
HeartSciences Inc.
- Market cap
- 30-day
- Sector
- Health Care
- Industry
- Industrial Specialties
- Listed since
- 2022
Get push alerts for HSCS
Full HSCS profile on Quantisnow Follow HSCS and get a push notification the moment its next story breaks.